HRT Financial’s Vertical Aerospace Ltd. Warrants, each whole warrant exercisable for 1/10th of an ordinary share at an exercise price of $115.00 per share EVTL.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-30,448
Closed -$11K 3662
2022
Q2
$11K Sell
30,448
-1,768
-5% -$1.18K ﹤0.01% 2673
2022
Q1
$25K Sell
32,216
-955
-3% -$736 ﹤0.01% 2810
2021
Q4
$22K Buy
+33,171
New +$32K ﹤0.01% 2940

Other funds holding EVTL.WS

HRT Financial's EVTL.WS Position: Q3 2022 in Review

HRT Financial sold out of Vertical Aerospace Ltd. Warrants, each whole warrant exercisable for 1/10th of an ordinary share at an exercise price of $115.00 per share (EVTL.WS) in Q3 2022, closing a stake of 30,448 shares — an estimated $11K sold.

HRT Financial first reported a position in EVTL.WS in Q4 2021 and held it in 3 quarters. The position peaked at $25K in Q1 2022. 24 funds tracked by Wall St. Rank hold EVTL.WS as of Q3 2022.

  • HRT Financial reported no remaining Vertical Aerospace Ltd. Warrants, each whole warrant exercisable for 1/10th of an ordinary share at an exercise price of $115.00 per share position as of Q3 2022 after selling out during the quarter.
  • HRT Financial sold 30,448 Vertical Aerospace Ltd. Warrants, each whole warrant exercisable for 1/10th of an ordinary share at an exercise price of $115.00 per share shares in Q3 2022, an estimated $11K.
  • HRT Financial first reported a position in Vertical Aerospace Ltd. Warrants, each whole warrant exercisable for 1/10th of an ordinary share at an exercise price of $115.00 per share in Q4 2021 and held it in 3 quarters.
  • HRT Financial's Vertical Aerospace Ltd. Warrants, each whole warrant exercisable for 1/10th of an ordinary share at an exercise price of $115.00 per share position peaked at $25K in Q1 2022.
  • 24 funds tracked by Wall St. Rank held Vertical Aerospace Ltd. Warrants, each whole warrant exercisable for 1/10th of an ordinary share at an exercise price of $115.00 per share as of Q3 2022.

Based on HRT Financial's 13F filing for Q3 2022, filed 14 Nov 2022.